Sun Choi

Recommended Articles

• Should I Go on Birth Control if I Have Endometriosis?

  Endometriosis is a condition marked by the growth of the tissues lining the inner part of uterus, towards the outer side of uterus. It is a non-curable condition that affects many women in their reproductive years. It is a very painful disorder and often treated with painkillers and hormone...

• Preventing Exacerbations of COPD

  According to a statistic, 65 million people have moderate to severe chronic obstructive pulmonary disease (COPD) around the world. More than 3 million people have died because of COPD in 2005, which corresponds to 5 percent of all deaths globally. This puts COPD as one of the major causes of...

• How Emotional Intelligence Helps Ensure Patients' Safety

  There is no doubt that nursing is one of the most rewarding careers out there. Those individuals who choose to become nurses have the opportunity to help patients and families through some of the most difficult and rewarding times in their lives. From births to deaths, nurses are the soldiers that...

• Double Whammy Breast Cancer Treatment Reduces Toxicity

  A potential new therapeutic target has been identified to treat some cancer types, all the while avoiding harm to healthy cells and reducing side effects. The study, published in the journal Nature Communications, was led by a Scripps Research research team in California. It showed how a protein...

• How Nurses Can Prevent Violence in their Workplace

  The question “How nurses can prevent workplace violence?” is often asked by relatives of those who are working in the healthcare industry. After all, according to the report of OSHA (Occupational Safety and Health Administration) in 2013, more than 2 million workers in the United become a victim...

• FDA Approves Baricitinib for Adults with Active Rheumatoid Arthritis

  On June 1st of 2018, the US Food and Drug Administration (FDA) approved Olumiant (Baricitinib) for the treatment of adults with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more TNF inhibitor therapies. “We are pleased to provide RA...